Skip to main content
Erschienen in: Reactions Weekly 1/2014

01.09.2014 | Case report

Peginterferon-α-2a

Thrombocytopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Guglieri-Lopez B, et al. [Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C: two case reports]. Farmacia Hospitalaria 37: 419-21, No. 5, Sep 2013 [Spanish; summarised from a translation] - SpainPubMed Guglieri-Lopez B, et al. [Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C: two case reports]. Farmacia Hospitalaria 37: 419-21, No. 5, Sep 2013 [Spanish; summarised from a translation] - SpainPubMed
Metadaten
Titel
Peginterferon-α-2a
Thrombocytopenia: case report
Publikationsdatum
01.09.2014
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2014
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-014-3385-x

Weitere Artikel der Ausgabe 1/2014

Reactions Weekly 1/2014 Zur Ausgabe

Case report

Bendamustine

Case report

Vaccines